Detalhe da pesquisa
1.
Estimating the US Baseline Distribution of Health Inequalities Across Race, Ethnicity, and Geography for Equity-Informative Cost-Effectiveness Analysis.
Value Health
; 26(10): 1485-1493, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37414278
2.
The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis.
Value Health
; 26(2): 216-225, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36192293
3.
Stratification of BMI categories among older adults within and across countries.
Public Health Nutr
; 23(2): 254-263, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31258103
4.
Association of genetic and behavioral characteristics with the onset of diabetes.
BMC Public Health
; 19(1): 1297, 2019 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31615468
5.
FROM BIRTH TO ADULTHOOD: ANTHROPOMETRIC TRAJECTORIES AND THEIR IMPLICATIONS FOR CHRONIC DISEASES IN GUATEMALA.
J Biosoc Sci
; 51(2): 292-306, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30295209
6.
Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA.
J Comp Eff Res
; 13(2): e230119, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38294335
7.
Clinical Outcomes in Patients With Refractory Anemia With Excess Blasts (RAEB) Who Receive Hypomethylating Agents (HMAs).
Clin Lymphoma Myeloma Leuk
; 24(3): 177-186, 2024 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996264
8.
The Association of Retinal Disease with Vision Impairment and Functional Status in Medicare Patients.
J Health Econ Outcomes Res
; 11(1): 94-102, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38560652
9.
US cost-effectiveness analysis of polatuzumab vedotin in previously untreated diffuse large B-cell lymphoma.
J Med Econ
; 26(1): 1134-1144, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37674384
10.
Cost of Disease Progression in Diffuse Large B-Cell Lymphoma After Frontline Treatment With Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Clin Lymphoma Myeloma Leuk
; 23(11): e393-e404, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37704514
11.
The Association Between Persistence and Adherence to Disease-Modifying Therapies and Healthcare Resource Utilization and Costs in Patients With Multiple Sclerosis.
J Health Econ Outcomes Res
; 9(1): 111-116, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35586512
12.
Adherence to and Persistence with Disease-Modifying Therapies for Multiple Sclerosis Over 24 Months: A Retrospective Claims Analysis.
Neurol Ther
; 11(1): 337-351, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35020156
13.
Persistence and adherence to ocrelizumab compared with other disease-modifying therapies for multiple sclerosis in U.S. commercial claims data.
J Manag Care Spec Pharm
; 27(5): 639-649, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33624535
14.
What your genes can (and can't) tell you about BMI and diabetes.
Biodemography Soc Biol
; 66(1): 40-49, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33682573
15.
In, out, and fluctuating: obesity from adolescence to adulthood.
Ann Epidemiol
; 41: 14-20, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31901410
16.
Beyond recent BMI: BMI exposure metrics and their relationship to health.
SSM Popul Health
; 11: 100547, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32195313
17.
Errors in body mass index from self-reported data by sex and across waves of Add Health.
Ann Epidemiol
; 39: 21-25, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31607420
18.
Biases in self-reported height and weight measurements and their effects on modeling health outcomes.
SSM Popul Health
; 7: 100405, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-31193386
19.
Global analysis of overweight prevalence by level of human development.
J Glob Health
; 5(2): 020413, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26682046